Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
oleanolic acid/inflammation
リンクがクリップボードに保存されます
ページ 1 から 22 結果
Antioxidant inflammation modulators: novel derivatives of oleanolic acid
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present disclosure relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: novel derivatives of oleanolic acid
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present disclosure relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present disclosure relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present disclosure relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present disclosure relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present invention relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present invention relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present invention relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present invention relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present invention relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present invention relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present invention relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at C-17
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present invention relates generally to the fields of biology and medicine. More particularly, it concerns compounds and methods for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
II.
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
The sequence listing that is contained in the file named "REATP0076USCP1D1_ST25.txt", which is .about.1 KB (as measured in Microsoft Windows.RTM.) and was created on Nov. 7, 2014, is filed herewith by electronic submission and is incorporated by reference herein.
BACKGROUND OF THE INVENTION
I. Field
C13-hydroxy derivatives of oleanolic acid and methods of use thereof
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Pursuant to 37 C.F.R. 1.821(c), a sequence listing is submitted herewith as an ASCII compliant text file named "REATP0078US_SequenceListing_ST25.txt", created on Sep. 10, 2013 and having a size of .about.1 KB. The content of the aforementioned file is hereby incorporated by reference in its
科学に裏打ちされた最も完全な薬草データベース
- 55の言語で動作します
- 科学に裏打ちされたハーブ療法
- 画像によるハーブの認識
- インタラクティブGPSマップ-場所にハーブをタグ付け（近日公開）
- 検索に関連する科学出版物を読む
- それらの効果によって薬草を検索する
- あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください
症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています
